XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
Class A
Common Shares
Class B
Common Shares
Preferred Convertible Series A Shares
Preferred Convertible Series B Shares
Preferred Convertible Series C Shares
Preferred Convertible Series F Shares
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Stockholders Deficit
Other Comprehensive Income
Noncontrolling Interest
Total
Balance at Jul. 31, 2020     $ 101 $ 86,364 $ (88,697) $ (2,231) $ 1 $ (382) $ (2,613)
Balance (in Shares) at Jul. 31, 2020     225,000 407,477 101,323,590            
Amortization of employee stock options           135 135 135
Amortization of employee stock options (in Shares)                        
Common stock issued for services, to employees       $ 8 257 265 265
Common stock issued for services, to employees (in Shares)         7,858,820            
Common stock issued for services     $ 4 219 223   223
Common stock issued for services (in Shares)     4,250,000            
Common stock issued for debt conversion and settlement     $ 21 407 428 428
Common stock issued for debt conversion and settlement (in Shares)     21,275,629            
Common stock issued concurrent with convertible debt       $ 2 145 147 147
Common stock issued concurrent with convertible debt (in Shares)       2,100,000            
Beneficial conversion feature on convertible debt               282 282 282
Common stock issued for settlement of accounts payable           $ 1 59 60 60
Common stock issued for settlement of accounts payable (in Shares)             1,000,000            
Common stock issued for exercise of warrants     $ 1 33 34 34
Common stock issued for exercise of warrants (in Shares)     330,000            
Common stock issued, extension of debt     $ 1 59 60 60
Common stock issued, extension of debt (in Shares)     400,000            
Convertible Series B Preferred stock issued for debt settlement     18 18 18
Convertible Series B Preferred stock issued for debt settlement (in Shares)     17,965            
Convertible Series C Preferred stock issued for AP settlement     554 554 554
Convertible Series C Preferred stock issued for AP settlement (in Shares)     55,400            
Super Voting Preferred Stock Series F      
Super Voting Preferred Stock Series F (in Shares)     100            
Derivative liability resolved to APIC due to note conversion     588 588 588
Derivative liability resolved to APIC due to note conversion (in Shares)                
Dividends declared     (20) (20) (20)
Dividends declared (in Shares)                
Net income (loss)                 (16,683) (16,683) (332) (17,015)
Balance at Jul. 31, 2021             $ 139 89,100 (105,380) (16,140) 1 (714) (16,854)
Balance (in Shares) at Jul. 31, 2021     225,000 425,442 55,400 100 138,538,039            
Balance at Feb. 17, 2021            
Balance (in Shares) at Feb. 17, 2021                      
Net income (loss)           (547) (547)      
Balance at Mar. 31, 2021           (547) (547)      
Balance (in Shares) at Mar. 31, 2021                      
Balance at Feb. 17, 2021            
Balance (in Shares) at Feb. 17, 2021                      
Net income (loss)                         (1,104,242)
Balance at Sep. 30, 2021 $ 16           316   (18,837,979) (18,837,647)      
Balance (in Shares) at Sep. 30, 2021 158,125 3,162,500                      
Balance at Feb. 17, 2021            
Balance (in Shares) at Feb. 17, 2021                      
Class B common stock issued to Sponsor   $ 316           24,684   25,000      
Class B common stock issued to Sponsor (in Shares)   3,162,500                      
Proceeds received in excess of fair value of private warrants               1,084,163   1,084,163      
Issuance of shares to underwriter representative at fair value $ 16             1,454,418   1,454,434      
Issuance of shares to underwriter representative at fair value (in Shares) 158,125                        
Remeasurement of common stock subject to possible redemption               (2,563,265) (17,733,737) (20,297,002)      
Net income (loss)                 5,906,214 5,906,214     5,906,214
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524) (11,827,192)     (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Balance at Mar. 31, 2021           (547) (547)      
Balance (in Shares) at Mar. 31, 2021                      
Class B common stock issued to Sponsor             316 24,684   25,000      
Class B common stock issued to Sponsor (in Shares)   3,162,500                      
Net income (loss)               (85) (85)      
Balance at Jun. 30, 2021           316 24,684 (632) 24,368      
Balance (in Shares) at Jun. 30, 2021 3,162,500                      
Issuance of 158,125 shares to underwriter representative at fair value $ 16           1,454,418 1,454,434      
Issuance of 158,125 shares to underwriter representative at fair value (in Shares) 158,125                      
Proceeds received in excess of fair value of private warrants             1,084,163 1,084,163      
Net income (loss)                 (1,103,610) (1,103,610)     (1,103,610)
Accretion of Class A common stock subject to possible redemption             (2,563,265) (17,733,737) (20,297,002)      
Balance at Sep. 30, 2021 $ 16           316   (18,837,979) (18,837,647)      
Balance (in Shares) at Sep. 30, 2021 158,125 3,162,500                      
Balance at Jul. 31, 2021             $ 139 89,100 (105,380) (16,140) 1 (714) (16,854)
Balance (in Shares) at Jul. 31, 2021     225,000 425,442 55,400 100 138,538,039            
Amortization of employee stock options     98 98 98
Amortization of employee stock options (in Shares)                
Common stock issued for debt extension       $ 1,000,000 64,000,000 65,000,000 65,000,000
Common stock issued for debt extension (in Shares)       550,000            
Common stock issued for services       $ 1 125 126 126
Common stock issued for services (in Shares)       1,500,000            
Common stock issued concurrent with convertible debt       $ 1 119 120 120
Common stock issued concurrent with convertible debt (in Shares)       1,500,000            
Dividends declared       (19) (19) (19)
Dividends declared (in Shares)                  
Net income (loss)                 (8,013) (8,013) (1,341) (9,354)
Balance at Jul. 31, 2022             $ 142 89,487 (113,393) (23,763) $ 1 $ (2,055) (25,818)
Balance (in Shares) at Jul. 31, 2022     225,000 425,442 55,400 100 142,088,039            
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524) (11,827,192)     (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Net income (loss)           3,976,791       3,976,791
Balance at Mar. 31, 2022 $ 16 $ 316           (7,850,733)       (7,850,401)
Balance (in Shares) at Mar. 31, 2022 158,125 3,162,500                      
Balance at Dec. 31, 2021 $ 16 $ 316           (11,827,524) $ (11,827,192)     (11,827,192)
Balance (in Shares) at Dec. 31, 2021 158,125 3,162,500                      
Net income (loss)                         5,369,223
Balance at Sep. 30, 2022 $ 16 $ 316           (8,059,563)       (8,059,231)
Balance (in Shares) at Sep. 30, 2022 158,125 3,162,500                      
Balance at Mar. 31, 2022 $ 16 $ 316           (7,850,733)       (7,850,401)
Balance (in Shares) at Mar. 31, 2022 158,125 3,162,500                      
Net income (loss)           1,959,110       1,959,110
Balance at Jun. 30, 2022 $ 16 $ 316             (5,891,623)       (5,891,291)
Balance (in Shares) at Jun. 30, 2022 158,125 3,162,500                      
Net income (loss)           (566,677)       (566,677)
Accretion of Class A common stock subject to possible redemption           (1,601,263)       (1,601,263)
Balance at Sep. 30, 2022 $ 16 $ 316           $ (8,059,563)       $ (8,059,231)
Balance (in Shares) at Sep. 30, 2022 158,125 3,162,500